跳至主要内容
临床试验/NCT02965313
NCT02965313进行中(未招募)不适用

Vaginal Surgery for the Pelvic Floor: A Randomized Trial of Synthetic Mesh Versus Synthetic Sutures

University of British Columbia2 个研究点 分布在 1 个国家目标入组 358 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
358
试验地点
2
主要终点
Composite outcome of 3 objective signs and 1 subjective symptom of POP (yes/no answers). The definition of surgical success, used in the OPTIMAL trial as described in the description below.

研究概览

简要总结

This is a Canadian, multi-centre, double-blind randomized controlled trial of an innovative vaginal surgery technique for correction of pelvic organ prolapse (POP) in women. Vaginal surgery is preferred as minimally invasive, however the investigators do not know if materials such as synthetic polypropylene mesh improve success, durability and cost-effectiveness long-term. The investigators principal goal is to compare the experimental bilateral sacrospinous vaginal vault fixation with synthetic mesh arms (BSSVF-M) to the current standard of sacrospinous ligament suspension with synthetic sutures (SSLS) over a timeline of 2 years. Patients and evaluators will be blind to technique.

详细描述

Background and Rationale:

The pelvic floor comprises muscles, nerves and a fascial network with dynamic, elastic ligaments of support. Pelvic organ prolapse (POP) occurs when the capacity to accommodate pressure and stretch is exceeded and increases with childbirth and aging. One in five women need surgery for POP. POP suspension performed vaginally is among the most important ideas in gynecology in the past few decades, however the investigators do not know which technique is best. The principal applicant has developed a novel surgery: bilateral sacrospinous vaginal vault fixation with synthetic mesh arms (BSSVF-M), which may be more successful, durable and cost-effective than standard sacrospinous ligament suspension with sutures (SSLS) and may thus become the preferred vaginal POP surgery both nationally and internationally. A Cochrane review on surgical management of POP concluded that "adequately powered RCTs with blinding of assessors are urgently needed [...] they particularly need to include women's perceptions." The OPTIMAL trial, a large RCT comparing 2 POP surgeries, established a stringent definition of success using a composite outcome of objectively measured POP, subjective improvement and the need for another treatment for POP recurrence.

Identifying the best way to surgically suspend the vagina for POP can make the difference between a woman who can enjoy a desired level of physical activity at work or play, empty her bowel and bladder without concerns, engage in a normal sexual life and a woman who can't perform these basic activities without discomfort, pain, worry and shame. The vaginal approach for pelvic surgery offers less pain, a shorter hospital stay, a faster recovery and no external incisions. However, what is the safest, most durable, most cost-effective vaginal POP surgery? Prior operations have produced unacceptable complications or a need for reoperation for POP recurrence. Further suffering for women and unacceptable healthcare costs ensued. Because seniors (over age 65) are the fastest growing age group in Canada, the CIHR states research into aging should be prioritized. By 2031, Statistics Canada estimates the number of senior women to reach 5.1 million or 24% of the total female population. Women have longer life expectancy than men. The burden of POP increases with age; 1 of 2 women over 80 experience pelvic floor dysfunction. For some aging women, vaginal surgery is the only option because of comorbidities precluding more invasive or lengthier open abdominal surgeries. Currently, there is true clinical equipoise between BSSVF-M and SSLS. Our novel mesh insertion technique, BSSVF-M, offers the advantages of small size, deep, tension-free and tailored to individual anatomy. This ensures midline restoration of the vaginal axis and maintains flexibility for normal bladder, bowel and sexual function. Tension-free insertion of BSSVF-M is a key difference with SSLS, which pulls the vagina tight against ligaments, causing pain or the return of POP after SSLS. Surgical innovation is important but adoption of new procedures needs reliable evidence acquired through a rigorous Innovation, Development, Exploration, Assessment, Long-term study (IDEAL) paradigm.

The investigators have been studying BSSVF-M over the past 9 years. Initial development included a magnetic resonance imaging study establishing restoration of pelvic anatomy comparable to normal. An exploratory prospective cohort study followed, showing BSSVF-M to be safe, easily taught to other surgeons and successful in 77% of women at one year, with the OPTIMAL composite outcome. This is superior to the reported 60% success of the SSLS and informed our power calculation for the proposed RCT. An informal survey of 50 Western Society for Pelvic Medicine surgeons indicated that an average of 14% increase in composite outcome success would be sufficient to adopt a new vaginal suspension technique. The investigators are now at the IDEAL assessment stage, where our novel technique warrants an RCT before widespread adoption. The results of this trial will directly inform surgeons whether mesh should be used for vaginal repair of POP and how to counsel patients. This trial includes knowledge translation for women to understand pelvic floor symptoms, related condition-specific quality of life, sexual health and body image after two vaginal surgery procedures. A rigorous cost effectiveness analysis will inform different stakeholders and policy makers regarding cost effectiveness.

Primary Objective:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women over 19 years of age
  • Able to read and write in English
  • Able to follow up with clinic visits for up to two years after surgery
  • Diagnosed with bothersome pelvic organ prolapse including at the top of the vagina

排除标准

  • Women who wish to conserve the uterus
  • Prior pelvic radiation
  • Prior vaginal mesh surgery for prolapse
  • Prior vaginal mesh exposure
  • Presence of vaginal pain from pelvic floor muscle spasm documented at baseline visit
  • Plan for synthetic vaginal mesh insertion for prolapse, at the same time, at locations other than the top of the vagina (NOTE: concurrent need for synthetic anti-incontinence sling is NOT an exclusion)
  • Immune compromise; chronic steroid use
  • Current smoker
  • Currently pregnant or breastfeeding
  • Presence of pain syndromes likely to cause a heightened sensitivity to pelvic pain (IE fibromyalgia or painful bladder syndrome)

结局指标

主要结局

Composite outcome of 3 objective signs and 1 subjective symptom of POP (yes/no answers). The definition of surgical success, used in the OPTIMAL trial as described in the description below.

时间窗: 2 years postoperatively

The Optimal Trial Outcome is the absence of all the following: (1) objectively recorded, via POP quantification (POP-Q)15, recurrent POP of the top of the vagina beyond the upper third of the vaginal canal; (2) objectively recorded, via POPQ, recurrent POP of the anterior or posterior vaginal walls beyond the hymenal ring (vaginal entrance); (3) vaginal bulge symptoms reported by the patient, as indicated by an affirmative response to either: "Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?" and any response other than "not at all" to the question "How much does that bother you?" (4) re-treatment for prolapse by either surgery or pessary (conservative treatment with insertion of a silicone ring in the vagina for support). The POPQ is a validated quantification system with adequate interrater reliability which measures, in centimeters, the extent of vaginal wall descent with respect to a reference point at the hymenal ring.

次要结局

  • Difference between the 2 groups in complications eg pain or mesh exposure, reoperations, other unexpected adverse events (categorized using Clavien Dindo classification system for surgical complications).(Time of surgery)
  • Difference between the 2 groups in length of surgery stay (categorized using Clavien Dindo classification system for surgical complications).(Time of surgery)
  • Difference in health utilities measured in direct healthcare utilization and costs collected by the healthcare service utilization questionnaire at baseline, 6 weeks, 6, 12 and 24 months postoperatively.(Baseline to 6 weeks, 6, 12 and 24 months postoperatively)
  • Change in maximal POP of vaginal compartments via POPQ, obtained by research personnel (nurse or clinical fellow) trained in POPQ and blinded to group allocation. POP will be quantified and compared to baseline.(Baseline to 6 weeks,12 and 24 months)
  • Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: Pelvic Floor Distress Inventory (PFDI-20)(Baseline to 6 weeks,12 and 24 months)
  • Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: Pelvic Floor Impact Questionnaire (PFIQ-7)(Baseline to 6 weeks, 12 and 24 months)
  • Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: the a validated gender-specific body image scale specifically for POP (BIPOP) Questionnaire(Baseline to 6 weeks, 12 and 24 months)
  • Change in questionnaire scores between the 2 groups from baseline to 12 and 24 months: Pelvic organ prolapse/ Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)(Baseline to 12 and 24 months)
  • Difference between the 2 groups in postoperative hospital stay (categorized using Clavien Dindo classification system for surgical complications).(Time of surgery)
  • Difference in health utilities measured via the EuroQol instrument (EQ-5D)and in direct healthcare utilization and costs collected by the healthcare service utilization questionnaire at baseline, 6 weeks, 6, 12 and 24 months postoperatively.(Baseline to 6 weeks, 6, 12 and 24 months postoperatively)
  • Change in questionnaire scores between the 2 groups from baseline to 6 weeks, 12 and 24 months postoperatively: the short form McGill pain questionnaire(Baseline to 6 weeks, 12 and 24 months)
  • Difference between global impression of improvement (Likert Scale) of the 2 groups at 6 weeks, 12 and 24 months postoperatively(Baseline to 6 weeks, 12 and 24 months postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Roxana Geoffrion

Dr. Roxana Geoffrion

University of British Columbia

研究点 (2)

Loading locations...

相似试验